Lack of involvement of haloperidol-sensitive sigma binding sites in modulation of dopamine neuronal activity and induction of dystonias by antipsychotic drugs
- 30 September 1992
- journal article
- Published by Elsevier in Neuropharmacology
- Vol. 31 (9) , 961-967
- https://doi.org/10.1016/0028-3908(92)90137-e
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Non-competitive antagonists are potent activators of ventral tegmental A10 dopamine neuronsNeuroscience Letters, 1990
- Neuroleptic-sensitive binding sites in the nigrostriatal system: evidence for differential distribution of sigma sites in the substantia nigra, pars compacta of the catJournal of Neuroscience, 1989
- Autoradiographic localization of sigma receptor binding sites in guinea pig and rat central nervous system with (+)3H-3-(3-hydroxyphenyl)-N-(1- propyl)piperidineJournal of Neuroscience, 1986
- Complete Conversion of Brain D2 Dopamine Receptors from the High‐ to the Low‐Affinity State for Dopamine Agonists, Using Sodium Ions and Guanine NucleotideJournal of Neurochemistry, 1985
- The effects of phencyclidine and N-allylnormetazocine on midbrain dopamine neuronal activityEuropean Journal of Pharmacology, 1984
- 8-Hydroxy-2-(dipropylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonistJournal of Medicinal Chemistry, 1981
- Nigral Dopamine Neurons: Intracellular Recording and Identification with L-Dopa Injection and HistofluorescenceScience, 1980
- Paradoxical GABA excitation of nigral dopaminergic cells: Indirect mediation through reticulata inhibitory neuronsEuropean Journal of Pharmacology, 1979
- Effects of the optical isomers of the narcotic antagonist analgesic pentazocine on brain and heart biogenic aminesEuropean Journal of Pharmacology, 1974
- Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reactionBiochemical Pharmacology, 1973